YDES – yd bio limited - ordinary shares (US:NASDAQ)
Stock Stats
News
YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
True Velocity, Inc./DE (NASDAQ:YDES) had its "sell (d+)" rating reaffirmed by analysts at Weiss Ratings.
True Velocity, Inc./DE (NASDAQ:YDES) is now covered by analysts at Weiss Ratings. They set a "sell (d+)" rating on the stock.
YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center
Form 6-K YD Bio Ltd For: Jan 16
Form 6-K YD Bio Ltd For: Jan 15
Form 6-K YD Bio Ltd For: Jan 06
Form S-8 YD Bio Ltd
Form SCHEDULE 13G YD Bio Ltd Filed by: Shen Ethan PhD
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.